Design Therapeutics
DSGN
DSGN
98 hedge funds and large institutions have $133M invested in Design Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
12% less call options, than puts
Call options by funds: $15K | Put options by funds: $17K
22% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 36
36% less capital invested
Capital invested by funds: $206M → $133M (-$73.4M)
Holders
98
Holding in Top 10
2
Calls
$15K
Puts
$17K
Top Buyers
| 1 | +$3.49M | |
| 2 | +$2.49M | |
| 3 | +$772K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$546K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$530K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$871K | |
| 3 | -$452K | |
| 4 |
BlackRock
New York
|
-$385K |
| 5 |
Morgan Stanley
New York
|
-$379K |
